DK1931704T3 - Frembringelse og rensning af IL-29 - Google Patents

Frembringelse og rensning af IL-29

Info

Publication number
DK1931704T3
DK1931704T3 DK06816409.4T DK06816409T DK1931704T3 DK 1931704 T3 DK1931704 T3 DK 1931704T3 DK 06816409 T DK06816409 T DK 06816409T DK 1931704 T3 DK1931704 T3 DK 1931704T3
Authority
DK
Denmark
Prior art keywords
methods
purification
generation
coli
vectors
Prior art date
Application number
DK06816409.4T
Other languages
English (en)
Inventor
Bruce L Zamost
Geoffrey F Lee
Robert M Dedinsky
Original Assignee
Zymogenetics L L C
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics L L C, Bristol Myers Squibb Co filed Critical Zymogenetics L L C
Application granted granted Critical
Publication of DK1931704T3 publication Critical patent/DK1931704T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
DK06816409.4T 2005-10-04 2006-10-04 Frembringelse og rensning af IL-29 DK1931704T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72354405P 2005-10-04 2005-10-04
PCT/US2006/039139 WO2007041713A1 (en) 2005-10-04 2006-10-04 Production and purification of il-29

Publications (1)

Publication Number Publication Date
DK1931704T3 true DK1931704T3 (da) 2011-03-14

Family

ID=37603659

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06816409.4T DK1931704T3 (da) 2005-10-04 2006-10-04 Frembringelse og rensning af IL-29

Country Status (15)

Country Link
US (6) US20080096252A1 (da)
EP (1) EP1931704B1 (da)
JP (3) JP5364375B2 (da)
AT (1) ATE491722T1 (da)
AU (1) AU2006299339B2 (da)
CA (1) CA2625208A1 (da)
CY (1) CY1112323T1 (da)
DE (1) DE602006018969D1 (da)
DK (1) DK1931704T3 (da)
ES (1) ES2357152T3 (da)
IL (2) IL189994A (da)
PL (1) PL1931704T3 (da)
PT (1) PT1931704E (da)
SI (1) SI1931704T1 (da)
WO (1) WO2007041713A1 (da)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7052686B2 (en) 2000-09-29 2006-05-30 Schering Corporation Pegylated interleukin-10
US7038032B2 (en) 2001-04-20 2006-05-02 Zymogenetics, Inc. Cytokine protein family
JP4808157B2 (ja) 2003-08-07 2011-11-02 ザイモジェネティクス リミテッド ライアビリティ カンパニー Il−28およびil−29の均一な調製物
EP1909821A2 (en) * 2005-07-20 2008-04-16 ZymoGenetics, Inc. Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders
JP2009502803A (ja) * 2005-07-20 2009-01-29 ザイモジェネティクス, インコーポレイテッド Il−28およびil−29のシステイン欠失変異体、ならびにそれを用いる抗ウイルス法
JP5364375B2 (ja) * 2005-10-04 2013-12-11 ザイモジェネティクス リミテッド ライアビリティ カンパニー Il−29の生産および精製の方法
AR067537A1 (es) 2007-07-17 2009-10-14 Hoffmann La Roche Purificacion de polipeptidos pegilados
CL2008002054A1 (es) 2007-07-17 2009-05-29 Hoffmann La Roche Metodo para la regeneracion de una columna de cromatografia de intercambio cationico despues de la elusion de eritropoyetina monopeguilada y metodo para obtener una eritropoyetina monopeguilada, incorporando el metodo de regeneracion de la columna de intercambio cationico.
US9051369B2 (en) 2007-09-20 2015-06-09 Commonwealth Scientific And Industrial Research Organisation Avian cytokines and genetic sequences encoding same
CN101918430A (zh) * 2008-01-18 2010-12-15 弗·哈夫曼-拉罗切有限公司 非糖基化蛋白质的纯化
RU2496514C2 (ru) * 2008-06-05 2013-10-27 Займоджинетикс, Инк. Применение пэгилированных интерферонов типа iii для лечения гепатита с
CA2742817A1 (en) 2008-11-20 2010-05-27 Biogen Idec Ma Inc. Arginine inactivation of viruses
ES2957546T3 (es) 2008-12-17 2024-01-22 Merck Sharp & Dohme Producción de mono- y di-PEG-IL10; y usos
CA2758298A1 (en) * 2009-04-10 2010-10-14 Ls9, Inc. Production of commercial biodiesel from genetically modified microorganisms
WO2011098644A2 (es) 2010-02-09 2011-08-18 Proyecto De Biomedicina Cima, S.L. Composiciones para el tratamiento de enfermedades infecciosas y tumorales
JP5768341B2 (ja) * 2010-08-04 2015-08-26 東ソー株式会社 Fc結合性タンパク質の製造方法
CN102584979B (zh) * 2011-01-18 2015-10-14 北京凯因科技股份有限公司 PEG化干扰素λ
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
EP2748328A4 (en) * 2011-08-25 2015-03-04 Nanogen Pharmaceutical Biotechnology PEG-INTERFERON LAMBDA 1 CONJUGATES
US8454947B1 (en) 2012-03-01 2013-06-04 Nanogen Pharmaceutical Biotechnology PEG-interferon lambda 1 conjugates
RU2549710C2 (ru) * 2012-06-29 2015-04-27 Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства (ФГБУ "ГНЦ Институт иммунологии" ФМБА России) Способ очистки рекомбинантного белка интерфероноподобного фактора iii типа
JP6086378B2 (ja) * 2012-11-30 2017-03-01 国立大学法人お茶の水女子大学 組み換えヒト膵臓リパーゼの調製方法
CN104045704B (zh) * 2013-03-11 2016-08-10 中国医学科学院基础医学研究所 PEG化重组人IFN-λ1、其制备方法和用途
EP2986306A4 (en) 2013-04-18 2016-12-07 Armo Biosciences Inc METHOD FOR USE OF INTERLEUKIN-10 FOR THE TREATMENT OF ILLNESSES AND SUFFERING
CA2914837A1 (en) 2013-06-17 2014-12-24 Armo Biosciences, Inc. Method for assessing protein identity and stability
EP3022218A1 (en) * 2013-07-19 2016-05-25 Biogenomics Limited Apparatus for refolding of recombinant proteins
US10010588B2 (en) 2013-08-30 2018-07-03 Armo Biosciences, Inc. Methods of using pegylated interleukin-10 for treating hyperlipidemia
KR20160079114A (ko) 2013-11-11 2016-07-05 아르모 바이오사이언시스 인코포레이티드 질환 및 장애를 치료하기 위한 인터류킨-10을 사용하는 방법
CN109293782A (zh) * 2014-01-08 2019-02-01 德益阳光生物技术(北京)有限责任公司 融合多肽及使用方法
US11311519B2 (en) 2014-05-01 2022-04-26 Eiger Biopharmaceuticals, Inc. Treatment of hepatitis delta virus infection
US10076512B2 (en) 2014-05-01 2018-09-18 Eiger Biopharmaceuticals, Inc. Treatment of hepatitis delta virus infection
WO2015187295A2 (en) 2014-06-02 2015-12-10 Armo Biosciences, Inc. Methods of lowering serum cholesterol
EP3206713A4 (en) 2014-10-14 2018-06-27 Armo Biosciences, Inc. Interleukin-15 compositions and uses thereof
AU2015336101A1 (en) 2014-10-22 2017-04-20 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
CN107108712A (zh) * 2014-12-23 2017-08-29 阿尔莫生物科技股份有限公司 提高重组蛋白产量的方法
US10618970B2 (en) 2015-02-03 2020-04-14 Armo Biosciences, Inc. Method of treating cancer with IL-10 and antibodies that induce ADCC
HUE054068T2 (hu) 2015-04-21 2021-08-30 Eiger Biopharmaceuticals Inc Lonafarnibot és Ritonavirt tartalmazó gyógyszerkészítmények
WO2016191587A1 (en) 2015-05-28 2016-12-01 Armo Biosciences, Inc. Pegylated interleukin-10 for use in treating cancer
CA2995120A1 (en) 2015-08-25 2017-03-02 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
RS61944B1 (sr) 2016-02-19 2021-07-30 Eiger Biopharmaceuticals Inc Lečenje infekcije hepatitis delta virusom sa interferonom lambda
CA3041533A1 (en) * 2016-11-07 2018-05-11 Seattle Genetics, Inc. Distribution of engineered-cysteine caps
EP3927733A4 (en) * 2019-02-24 2022-07-06 Oncosimis Biotech Private Limited PROCESS FOR THE CONTINUOUS PRODUCTION OF RECOMBINANT GLP-1 PEPTIDE BY BACTERIA

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795077A (en) * 1988-05-23 1989-01-03 Motorola Inc. Bonding method and apparatus
EP0626448A3 (de) * 1993-05-26 1998-01-14 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung und Reinigung von alpha-Interferon
JP2002531089A (ja) * 1998-11-30 2002-09-24 イーライ・リリー・アンド・カンパニー 赤血球産生性化合物
CZ299516B6 (cs) * 1999-07-02 2008-08-20 F. Hoffmann-La Roche Ag Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
ES2286128T3 (es) * 2000-06-30 2007-12-01 Zymogenetics, Inc. Proteina zcyto21 tipo interferon.
US7038032B2 (en) * 2001-04-20 2006-05-02 Zymogenetics, Inc. Cytokine protein family
CA2503305A1 (en) * 2002-10-23 2004-05-06 Zymogenetics, Inc. Methods for treating viral infection using il-28 and il-29
MXPA05006117A (es) * 2002-12-13 2005-09-30 Zymogenetics Inc Produccion de il-21 en hospederos procarioticos.
JP4808157B2 (ja) * 2003-08-07 2011-11-02 ザイモジェネティクス リミテッド ライアビリティ カンパニー Il−28およびil−29の均一な調製物
AU2005231476B2 (en) 2004-04-02 2011-09-01 Zymogenetics, Inc. Il-28 and il-29 cysteine mutants for treating viral infection
US7351689B2 (en) * 2004-07-29 2008-04-01 Zymogenetics, Inc. Use of IL-28 and IL-29 to treat cancer and autoimmune disorders
CN1305902C (zh) * 2004-11-25 2007-03-21 汕头大学医学院 一种人白细胞介素29的生产方法及重组il-29工程菌
DK1828239T3 (da) * 2004-12-10 2011-12-19 Zymogenetics Inc FGF18-produktion i prokaryote værter
EP1909821A2 (en) * 2005-07-20 2008-04-16 ZymoGenetics, Inc. Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders
JP5364375B2 (ja) 2005-10-04 2013-12-11 ザイモジェネティクス リミテッド ライアビリティ カンパニー Il−29の生産および精製の方法

Also Published As

Publication number Publication date
SI1931704T1 (sl) 2011-04-29
JP2009510173A (ja) 2009-03-12
JP5364375B2 (ja) 2013-12-11
JP2012235789A (ja) 2012-12-06
IL189994A (en) 2013-08-29
US20120271037A1 (en) 2012-10-25
US8759027B2 (en) 2014-06-24
US20080096252A1 (en) 2008-04-24
US20100003722A1 (en) 2010-01-07
IL189994A0 (en) 2008-08-07
AU2006299339A1 (en) 2007-04-12
IL227691A0 (en) 2013-09-30
US20130143270A1 (en) 2013-06-06
ATE491722T1 (de) 2011-01-15
US7968315B2 (en) 2011-06-28
PL1931704T3 (pl) 2011-06-30
EP1931704A1 (en) 2008-06-18
ES2357152T3 (es) 2011-04-19
US20100222552A1 (en) 2010-09-02
US8211670B2 (en) 2012-07-03
DE602006018969D1 (de) 2011-01-27
US20120015403A1 (en) 2012-01-19
PT1931704E (pt) 2011-03-28
AU2006299339B2 (en) 2012-03-15
EP1931704B1 (en) 2010-12-15
JP2013099337A (ja) 2013-05-23
CA2625208A1 (en) 2007-04-12
CY1112323T1 (el) 2015-12-09
WO2007041713A1 (en) 2007-04-12
US7759092B2 (en) 2010-07-20

Similar Documents

Publication Publication Date Title
IL227691A0 (en) Creation and purification of 29 – il
CY1110734T1 (el) Μεθοδος παραγωγης μονιμων ανθρωπινων κυτταρικων σειρων
ATE492633T1 (de) Polypeptide mit cellobiohydrolaseaktivität und dafür kodierende polynukleotide
AR053066A1 (es) Arabinofuranosidasas
CY1110860T1 (el) Αναστροφη μεταγραφαση τελομερασης πτηνου
CL2007001335A1 (es) Anticuerpo anti cd40; acido nucleico que lo codifica; celula; cultivo celular; metodo de produccion; composicion farmaceutica; metodo para seleccionar un anticuerpo anti cd40; y su uso para tratar sintomas de un trastorno autoinmune y/o un trastorno inflamatorio y/o para reducir el rechazo al injerto y/o para el tratamiento de cancer positivos a cd40.
BR112012019023A2 (pt) método para produzir adenovírus recombinante sorotipo 26 (rad26), e, usoi de um biorreator
EA201170638A1 (ru) Способ получения аденовирусных векторов
CL2008001673A1 (es) Dominio variable simple de la inmunoglobulina del receptor tipo 1 de la anti-interleucina 1 (il-1r1); acido nucleico que lo codifica; vector y celula huesped; metodo de produccion; antagonista de il-1r1 que lo comprende; composicion que comprende al antagonista; y uso del antagonista para tratar una condicion inflamatoria.
IN2012DN02120A (da)
PT1941027E (pt) Métodos e meios para proliferação de células estaminais e subsequente geração e expansão de células progenitoras, bem como produção de células efectoras como produtos terapêuticos clínicos
EP2516624A4 (en) CELL LINE 3M
AR056256A1 (es) Plantas resistentes al estres
UA99700C2 (ru) Способ приготовления иммортализированной человеческой клеточной линии
WO2011021105A3 (en) Generation and reproduction of dna sequences and analysis of polymorphisms and mutations by using error-correcting codes
ATE515568T1 (de) Polypeptide mit endoglucanase-aktivtät und dafür codierende polynukleotide
ATE521633T1 (de) Fgf18 produktion in prokaryotischen zellen
BR112012017243A2 (pt) constructos terapêuticos de apirase, agentes de apirase, e métodos de produção
EA200701592A1 (ru) Композиты и способы их получения и использования
CL2011000398A1 (es) Secuencias codificantes para proteinas con actividad gpt, vectores y celulas que comprenden dichas secuencias, procedimientos para mejorar las caracteristicas de crecimiento, resistencia a salinidad y la eficiencia de la utilizacion de nitrogeno en plantas.
ATE447013T1 (de) Polypeptide mit endoglucanase-aktivtät und dafür codierende polynukleotide
DK1587932T3 (da) Plantetransformation med in vivo samling af et træk
AR051506A1 (es) Polipeptidos con actividad antimicrobiana y polinucleotidos que los codifican
FI20065035A7 (fi) Olennaisesti puhdas entsyymi
NO20055228L (no) Stamceller med okt sensitivitet for SDF-1 og fremgangsmate for fremstilling og anvendelse derav